| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 18,184,000 | 29,502,000 | 29,584,000 | 32,910,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 18,184,000 | 29,502,000 | 29,584,000 | 32,910,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 13,098,000 | 13,112,000 | 12,893,000 | 10,748,000 | | Non Recurring | 103,000 | 143,000 | 205,000 | 181,000 | | Others | 8,358,000 | 8,296,000 | 8,871,000 | 15,524,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 21,356,000 | 7,951,000 | 7,615,000 | 6,457,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 34,046,000 | 7,951,000 | 7,615,000 | 6,457,000 | | Interest Expense | 3,523,000 | 3,879,000 | 4,559,000 | 7,799,000 | | Income Before Tax | 30,523,000 | 4,072,000 | 3,056,000 | (1,342,000) | | Income Tax Expense | 1,551,000 | 1,351,000 | 915,000 | (719,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,588,000 | 2,721,000 | 2,141,000 | (623,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| 1,325,000 | | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,588,000 | 2,721,000 | 2,141,000 | 702,000 | | Preferred Stock And Other Adjustments |
-
| (1,649,000) | (622,000) | (423,000) | | | Net Income Applicable To Common Shares | $3,234,000 | $1,072,000 | $1,519,000 | $279,000 |
|
0.81% Nasdaq 
Income Statement
